Home

JEAN JACQUES BIENAIME

CIK 1221590 · Chief Executive Officer · last filed 2026-07-17

JEAN JACQUES BIENAIME is a Chief Executive Officer who has filed 462 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing shows the insider bought $10.6K of KROS on Jul 17, 2026. Across all open-market trades the lifetime net is −$240.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $33.8M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$33.83M

Companies

6

Total Filings

462

Lifetime Open-Market Net

-$240.33M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
KROS Director 18,592 $10.07 $187.2K $65.5K 8 2026-07-17
IMNM Director 38,915 $23.22 $903.6K $437.4K 12 2026-06-12
INCY Director 24,424 $129.93 $3.17M $320.5K 45 2026-06-10
ASND Director 600 $254.44 $152.7K $206.7K 2 2026-06-01
BMRN Director 473,892 $62.07 $29.41M -$241.37M 336 2024-05-21
PORTOLA PHARMACEUTICALS INC (PTLA) Delisted Director 1,706 — — $3.9K 4 2014-03-10

Recent Filings

462 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-17 KROS Buy (P) +1,000 $10.6K EDGAR
2026-06-17 KROS Buy (P) +1,000 $10.2K EDGAR
2026-06-12 IMNM Grant (A) — $0 EDGAR
2026-06-10 INCY Grant (A) +1,642 $0 EDGAR
2026-06-09 IMNM Mixed — $440 EDGAR
2026-06-05 KROS Grant (A) +7,142 $0 EDGAR
2026-06-01 ASND Buy (P) +500 $111.6K EDGAR
2026-05-28 INCY Mixed +1,941 -$79 EDGAR
2026-05-27 ASND Buy (P) +400 $95.1K EDGAR
2026-05-19 KROS Buy (P) +1,000 $10.6K EDGAR
Showing 1–10 of 462
Page 1 of 47
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.